Dive into the latest market news and views from the Freetrade team.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
March 1, 2021
How Argo Blockchain works
Crypto mining enables bitcoin but faces high costs, energy demands and big risks.
February 26, 2021
Has Fundsmith made the Rightmove?
Record traffic but falling profits leave Rightmove facing key questions.
February 24, 2021
SPAC madness hits Churchill-Lucid merger
SPACs: hype, risks, and how to judge blank-cheque deals before buying wisely now
February 23, 2021
Cellular Goods IPO
Cellular Goods joins the LSE amid CBD hype, big plans, no products yet and real risks.
February 22, 2021
Deliveroo IPO: what you need to know
Deliveroo eyes a timely IPO after fast growth, new partners and rising sector demand.
February 22, 2021
Cokeās weird origins
Coca-Colaās long rise continues, but sugar taxes and health trends test future growth.
February 18, 2021
Are UK banks a buy?
UK banks face loan risks and low rates while recovery hopes and returning dividends lift sentiment.
February 17, 2021
Why did Palantir shares crash on Tuesday?
Palantirās growth slows, losses persist and lockup expiry spooks investors
February 15, 2021
Why the pot stock rally just ended
Cannabis stocks spike then sink as mergers, hype and law change collide
February 15, 2021
The chipmaker at the heart of US-China tensions
TSMC: chip boom winner caught between USāChina rivalry and supply shocks
February 11, 2021
Can Bumble IPO buzz topple Tinder?
Bumbleās IPO marks a big step in its challenge to Tinder. Hereās what the appās numbers, strategy and expansion plans reveal for potential investors.
February 11, 2021
AstraZeneca is back in growth mode
Why AstraZenecaās share price isnāt rising with its vaccine progress.